Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CLPT

ClearPoint Neuro Inc

Oct 23 • 04:00PM ET

25.27

+0.98 4.03 %

Healthcare • Medical Devices • USA • NASD

Peers: AXNX NVCR NNOX NURO ARVN STXS PAVM LAKE LCTX BCLI

| Held by: VTI IWM VXF IWO VTWO IWC GSSC VTWG RSSL FDHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.80	Insider Own	14.27%	Shs Outstand	28.42M	Perf Week	-0.04%
Market Cap	718.36M	Forward P/E	-	EPS next Y	-0.68	Insider Trans	-1.65%	Shs Float	24.37M	Perf Month	31.07%
Enterprise Value	712.28M	PEG	-	EPS next Q	-0.20	Inst Own	33.38%	Short Float	10.55%	Perf Quarter	125.02%
Income	-22.22M	P/S	21.39	EPS this Y	-15.00%	Inst Trans	4.24%	Short Ratio	3.18	Perf Half Y	76.84%
Sales	33.59M	P/B	36.38	EPS next Y	16.15%	ROA	-38.50%	Short Interest	2.57M	Perf YTD	64.30%
Book/sh	0.69	P/C	17.29	EPS next 5Y	-	ROE	-85.68%	52W High	30.10 -16.05%	Perf Year	91.01%
Cash/sh	1.46	P/FCF	-	EPS past 3/5Y	-0.23% -10.69%	ROIC	-40.50%	52W Low	9.76 158.91%	Perf 3Y	168.54%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	24.42% 22.85%	Gross Margin	60.42%	Volatility	8.76% 10.17%	Perf 5Y	210.06%
Dividend TTM	-	EV/Sales	21.21	EPS Y/Y TTM	-13.17%	Oper. Margin	-67.33%	ATR (14)	2.12	Perf 10Y	-14.16%
Dividend Ex-Date	-	Quick Ratio	6.45	Sales Y/Y TTM	19.68%	Profit Margin	-66.15%	RSI (14)	59.60	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	7.30	EPS Q/Q	-28.72%	SMA20	-0.03%	Beta	1.28	Target Price	29.00
Payout	-	Debt/Eq	1.80	Sales Q/Q	17.27%	SMA50	48.85%	Rel Volume	0.58	Prev Close	24.29
Employees	115	LT Debt/Eq	1.78	Earnings	Aug 12 AMC	SMA200	76.69%	Avg Volume	809.29K	Price	25.27
IPO	May 21, 2012	Option/Short	Yes / Yes	EPS/Sales Surpr.	-5.00% 0.16%	Trades		Volume	466,212	Change	4.03%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-25-24	Resumed	B. Riley Securities	Buy	$10
Oct-24-23	Initiated	Stifel	Buy	$8
Feb-16-23	Resumed	B. Riley Securities	Buy	$14
Apr-05-22	Resumed	B. Riley Securities	Buy	$15
Mar-18-21	Initiated	Lake Street	Buy	$32
Jul-17-20	Initiated	B. Riley FBR	Buy	$8

Oct-07-25 04:15PM	ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles (ACCESSWIRE) +12.16%
Oct-06-25 04:10PM	ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide (ACCESSWIRE)
08:04AM	CLPT Expands Into Robotic System Supporting Cell and Gene Therapies (Zacks)
Oct-01-25 04:05PM	ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System (ACCESSWIRE) +19.80%
Sep-25-25 04:05PM	ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer (ACCESSWIRE) +9.17%
04:37PM	Loading…
Sep-24-25 04:37PM	Here's why biotech UniQure's stock just tripled, and brought ClearPoint shares up with it (MarketWatch) +58.55%
Sep-04-25 04:05PM	ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners (ACCESSWIRE) +8.10%
Aug-13-25 03:12AM	ClearPoint Neuro Inc (CLPT) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com) +13.09%
Aug-12-25 06:05PM	ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:05PM	ClearPoint Neuro Reports Second Quarter 2025 Results (ACCESSWIRE)
Aug-11-25 09:34AM	ClearPoint Neuro Inc (CLPT) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Aug-07-25 06:15PM	RxSight, Inc. (RXST) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
Aug-04-25 04:05PM	ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio (ACCESSWIRE) +5.30%
Jul-23-25 04:05PM	ClearPoint Neuro to Announce Second Quarter 2025 Results August 12, 2025 (ACCESSWIRE)
Jun-09-25 02:15PM	ClearPoint Neuro, Inc. (CLPT): A Bull Case Theory (Insider Monkey)
08:55AM	Loading…
Jun-04-25 08:55AM	Lake Street says AMT-130 could be significantly impactful for ClearPoint (TipRanks)
May-15-25 08:06AM	5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil (Zacks)
May-14-25 03:16AM	ClearPoint Neuro Inc (CLPT) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges (GuruFocus.com) -12.46%
May-13-25 05:35PM	ClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:40PM	ClearPoint Neuro Reports First Quarter 2025 Results (ACCESSWIRE)
09:55AM	Wall Street Analysts Believe ClearPoint Neuro (CLPT) Could Rally 102.86%: Here's is How to Trade (Zacks)
May-12-25 04:05PM	ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing (ACCESSWIRE)
09:34AM	ClearPoint Neuro Inc (CLPT) Q1 2025 Earnings Report Preview: What to Look For (GuruFocus.com)
May-08-25 05:45PM	Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +7.22%
May-07-25 05:40PM	OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-01-25 07:50AM	Teleflex (TFX) Tops Q1 Earnings and Revenue Estimates (Zacks)
Apr-30-25 05:10AM	Deep Sail Capital Partner Q1 2025 Investor Letter (Seeking Alpha)
Apr-29-25 12:00AM	ClearPoint Neuro: Fundamentals Continue To Strengthen (Seeking Alpha)
Apr-28-25 08:00AM	ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI (ACCESSWIRE)
Apr-25-25 08:00AM	ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025 (ACCESSWIRE)
08:00AM	Loading…
Apr-24-25 08:00AM	ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 - Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room (ACCESSWIRE) +7.85%
Apr-10-25 05:47AM	IDEXX (IDXX) Surges 10.0%: Is This an Indication of Further Gains? (Zacks) -8.08%
Feb-26-25 04:05PM	ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results (ACCESSWIRE) -17.51%
Feb-25-25 10:55AM	ClearPoint Neuro Inc (CLPT) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Feb-14-25 08:00AM	ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025 (ACCESSWIRE)
Feb-12-25 04:15PM	ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula (ACCESSWIRE)
Jan-29-25 08:32AM	ClearPoint Neuro price target raised to $20 from $15 at B. Riley (TipRanks)
Jan-28-25 09:20AM	ClearPoint Neuro, Inc. (CLPT): A Bull Case Theory (Insider Monkey) +5.53%
Jan-27-25 04:05PM	ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0 (ACCESSWIRE)
Nov-13-24 06:15PM	ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain (ACCESSWIRE)
Nov-07-24 04:05PM	ClearPoint Neuro Reports Third Quarter 2024 Results (ACCESSWIRE) -13.19%
Nov-06-24 07:38AM	ClearPoint Neuro Inc (CLPT) Q3 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-31-24 04:05PM	ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024 (ACCESSWIRE)
Oct-17-24 04:05PM	ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024 (GlobeNewswire) +11.61%
Aug-26-24 04:05PM	ClearPoint Neuro Announces Early Repayment of $10 Million Note (GlobeNewswire) +8.97%
Aug-07-24 04:05PM	ClearPoint Neuro Reports Second Quarter 2024 Results (GlobeNewswire) +40.68%
Jul-17-24 04:05PM	ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024 (GlobeNewswire)
Jul-10-24 03:51AM	Strength Seen in ClearPoint Neuro (CLPT): Can Its 16.9% Jump Turn into More Strength? (Zacks) +9.88%
Jun-20-24 08:45AM	ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint Navigation System for All Enrolled Patients in ASPIRO Clinical Trial (GlobeNewswire) +5.52%
08:30AM	Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons (PR Newswire)
Jun-03-24 11:53AM	ClearPoint's (CLPT) New Products to Boost Neurosurgical Segment (Zacks)
Jun-01-24 09:00AM	ClearPoint Neuro Announces Full Market Release of SmartFrame OR and ClearPoint PRISM 3T Laser Therapy System (GlobeNewswire)
May-29-24 09:55AM	Does ClearPoint Neuro (CLPT) Have the Potential to Rally 81.49% as Wall Street Analysts Expect? (Zacks)
May-13-24 09:55AM	Wall Street Analysts Predict a 70.65% Upside in ClearPoint Neuro (CLPT): Here's What You Should Know (Zacks)
May-08-24 03:53AM	ClearPoint Neuro Inc (CLPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth ... (GuruFocus.com)
May-07-24 08:58PM	CLPT Stock Earnings: ClearPoint Neuro Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:05PM	ClearPoint Neuro Reports First Quarter 2024 Results (GlobeNewswire)
May-02-24 04:05PM	ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore (GlobeNewswire) +6.34%
May-01-24 04:30PM	7 Penny Stocks That Could Make You a Fortune (If You Dare) (InvestorPlace)
Apr-29-24 08:00AM	ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory (GlobeNewswire)
Apr-24-24 04:05PM	ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR Stereotactic System (GlobeNewswire)
Apr-23-24 04:05PM	ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024 (GlobeNewswire)
Apr-16-24 04:05PM	ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations (GlobeNewswire)
Mar-27-24 08:32AM	Why ClearPoint Neuro (CLPT) Stock Might be a Great Pick (Zacks)
Mar-19-24 08:07AM	ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza as a Treatment for AADC Deficiency (GlobeNewswire)
Mar-16-24 03:39PM	ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-12-24 05:40PM	ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +18.51%
05:39PM	ClearPoint Neuro Inc Reports Robust Revenue Growth in Q4 and Full-Year 2023 (GuruFocus.com)
04:05PM	ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results (GlobeNewswire)
10:36AM	ClearPoint's (CLPT) Prism System Favored by Latest Study (Zacks)
Mar-11-24 08:00AM	Journal of Neurosurgery Publication Demonstrates Distinct Advantages of ClearPoint Prism Neuro Laser Therapy System (GlobeNewswire)
Mar-01-24 04:05PM	ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024 (GlobeNewswire)
Feb-29-24 08:00AM	ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stock (GlobeNewswire) -17.23%
Feb-28-24 04:45PM	ClearPoint Neuro Launches Proposed Public Offering of Common Stock (GlobeNewswire)
Feb-26-24 11:01AM	ClearPoint Neuro (CLPT) Gets FDA's Nod for New Software (Zacks)
Feb-21-24 04:05PM	ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain Model (GlobeNewswire)
Jan-24-24 04:05PM	ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo (GlobeNewswire) -7.39%
Jan-22-24 04:05PM	ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europe (GlobeNewswire)
Jan-17-24 10:38AM	ClearPoint Neuro (CLPT) Gets FDA's Nod for SmartFrame OR System (Zacks)
Jan-16-24 08:00AM	ClearPoint Neuro Announces FDA Clearance for SmartFrame OR Stereotactic System (GlobeNewswire) +5.30%
Jan-08-24 04:05PM	ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenue (GlobeNewswire) +17.91%
Nov-10-23 02:38PM	ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q3 2023 Earnings Call Transcript (Insider Monkey) -17.71%
Nov-09-23 04:05PM	ClearPoint Neuro Reports Third Quarter 2023 Results (GlobeNewswire) -7.82%
Oct-26-23 04:05PM	ClearPoint Neuro to Announce Third Quarter 2023 Results November 9, 2023 (GlobeNewswire) -6.02%
Aug-08-23 04:05PM	ClearPoint Neuro Reports Second Quarter 2023 Results (GlobeNewswire)
Jul-25-23 04:05PM	ClearPoint Neuro to Announce Second Quarter 2023 Results August 8, 2023 (GlobeNewswire)
May-24-23 09:25AM	ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery (GlobeNewswire)
May-18-23 04:01PM	ClearPoint Neuro to Present at the B. Riley Securities 2023 Institutional Investor Conference (GlobeNewswire)
May-11-23 04:05PM	ClearPoint Neuro Reports First Quarter 2023 Results (GlobeNewswire) -5.41%
May-10-23 04:05PM	ClearPoint Neuro to Present Investigational Research and Showcase Novel Innovations at the 26th American Society of Gene & Cell Therapy Annual Meeting in Los Angeles (GlobeNewswire)
Apr-28-23 04:42PM	ClearPoint Neuro to Announce First Quarter 2023 Results May 11, 2023 (GlobeNewswire)
Apr-20-23 04:05PM	ClearPoint Neuro to Showcase Two Novel Innovations at AANS 2023: ClearPoint Maestro® Brain Model and ClearPoint Prism Neuro Laser Therapy System (GlobeNewswire)
Apr-18-23 04:05PM	ClearPoint Neuro Announces Agreement with NE Scientific to Integrate Gene Therapy Infusion Coverage Tool into ClearPoint Maestro® Brain Model (GlobeNewswire)
12:33PM	Market Participants Recognise ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Revenues Pushing Shares 37% Higher (Simply Wall St.)
Apr-13-23 04:05PM	ClearPoint Neuro Announces ANVISA Approval of Neuro Navigation Portfolio in Brazil (GlobeNewswire) +11.01%
Apr-11-23 04:05PM	ClearPoint Neuro Extends Software License and Research Agreement with Philips to Include Fully Automatic Subnuclei Segmentation for DBS (GlobeNewswire)
Mar-28-23 04:05PM	ClearPoint Neuro Announces Exclusive Multi-Year Licensing Agreement with UCSF for Innovative Intra-Cerebral Cellular Delivery Platform (GlobeNewswire) +6.29%
Mar-01-23 04:05PM	ClearPoint Neuro Reports Fourth Quarter and Full-Year 2022 Results (GlobeNewswire) +7.19% -9.79%
Feb-15-23 04:05PM	ClearPoint Neuro to Announce Fourth Quarter and Full Year 2022 Revenue Results March 1, 2023 (GlobeNewswire)
Jan-11-23 08:00AM	ClearPoint Neuro Reports Fourth Quarter and Full Year 2022 Preliminary Revenue Results and Guidance for Full Year 2023 Revenue (GlobeNewswire)

Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The firm conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform consists of the ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Solana Beach, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BURNETT JOSEPH	CEO and President	Oct 10 '25	Sale	26.98	26,463	714,021	217,059	Oct 14 04:33 PM
JOSEPH M BURNETT TRUST	Affiliate of Director	Oct 10 '25	Proposed Sale	28.96	26,463	766,368		Oct 10 04:16 PM
Richards Timothy T.	Director	Jun 10 '25	Sale	13.28	10,000	132,800	77,381	Jun 12 07:26 PM
BURNETT JOSEPH	CEO and President	Jun 09 '25	Sale	13.29	21,247	282,373	243,522	Jun 11 09:50 PM
TIMOTHY RICHARDS	Director	Jun 10 '25	Proposed Sale	13.28	10,000	132,843		Jun 10 04:35 PM
JOSEPH M BURNETT TRUST	Officer	Jun 09 '25	Proposed Sale	13.29	21,247	282,358		Jun 09 04:08 PM
FALLON LYNNETTE C	Director	Jun 03 '25	Sale	12.57	10,200	128,226	40,901	Jun 05 04:17 PM
LYNNETTE FALLON	Director	Jun 03 '25	Proposed Sale	12.57	10,200	128,231		Jun 03 04:13 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CLPT

ClearPoint Neuro Inc

Upgrade your FINVIZ experience